(0.01%) 5 469.70 points
(0.02%) 39 119 points
(0.30%) 17 771 points
(-0.26%) $80.62
(-5.04%) $2.62
(-0.90%) $2 309.80
(-0.44%) $28.74
(3.07%) $1 016.70
(0.36%) $0.937
(0.74%) $10.68
(0.52%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems...
Stats | |
---|---|
Dagens volum | 407 765 |
Gjennomsnittsvolum | 920 482 |
Markedsverdi | 224.63M |
EPS | $-0.0614 ( Q1 | 2024-05-15 ) |
Neste inntjeningsdato | ( $0 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-14.52 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0360 (0.48%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-18 | Pimblett Emily | Sell | 5 000 | Restricted Stock Units |
2024-06-18 | Pimblett Emily | Buy | 5 000 | Common Stock |
2024-06-20 | Pimblett Emily | Sell | 1 245 | Common Stock |
2024-04-05 | Morisset Valerie | Buy | 17 847 | Common Stock |
2024-04-05 | Morisset Valerie | Sell | 17 847 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
35.73 |
Last 78 transactions |
Buy: 17 606 902 | Sell: 12 026 668 |
Volum Korrelasjon
Eliem Therapeutics, Inc. Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
THCP | 0.945 |
AGBA | 0.919 |
IZEA | 0.895 |
NISN | 0.893 |
STCN | 0.89 |
CSTE | 0.886 |
RILY | 0.881 |
CADL | 0.877 |
RILYZ | 0.864 |
CHCI | 0.859 |
10 Mest negative korrelasjoner | |
---|---|
ICLK | -0.946 |
VAXX | -0.922 |
LINK | -0.868 |
WVVI | -0.861 |
APDN | -0.851 |
SECO | -0.848 |
MRNS | -0.847 |
INTC | -0.84 |
KOPN | -0.834 |
DHCNI | -0.832 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Eliem Therapeutics, Inc. Korrelasjon - Valuta/Råvare
Eliem Therapeutics, Inc. Økonomi
Annual | 2023 |
Omsetning: | $0 |
Bruttogevinst: | $0 (0.00 %) |
EPS: | $-1.300 |
FY | 2023 |
Omsetning: | $0 |
Bruttogevinst: | $0 (0.00 %) |
EPS: | $-1.300 |
FY | 2022 |
Omsetning: | $0 |
Bruttogevinst: | $0 (0.00 %) |
EPS: | $-1.720 |
FY | 2021 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-3.05 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression, and focal onset seizures that is in Phase I clinical trial. The company also develops preclinical pipeline programs, such as Kv7 Program for pain, epilepsy, and depression; and Anxiolytic for the treatment of generalized anxiety disorder. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.